UP Initiates Major Pharmaceutical And Biotech Hub Projects

Lucknow: The Uttar Pradesh government is taking significant steps to bolster its presence in the pharmaceutical and biotechnology sectors. In a recent development, the state is working on establishing three key initiatives to further its mission in these fields. These endeavors are expected to position Uttar Pradesh as a prominent hub in pharmaceuticals and biotechnology.

One of the notable projects in the works is the construction of a state-of-the-art Meditech Park near Jewar Airport, which will span an expansive 350 acres. This park is set to accommodate over 100 industries dedicated to medical equipment production. Simultaneously, a massive Pharma Park covering 2,000 acres is being developed in Lalitpur, with a focus on manufacturing bulk drugs, starting materials, and active pharmaceuticals. This ambitious project aims to boost India’s self-reliance in the production of medical equipment and reduce dependence on imports, potentially turning the nation into an exporter of medical equipment and medicines.

Another crucial initiative involves the formulation of plans for a cutting-edge biotech park in Pilibhit. This park is envisioned to address the import of fermentation-based goods, contributing to self-sufficiency in this area. During a recent meeting at the Biotech Park, it was decided to establish a dedicated wing to facilitate the development, skill enhancement, and incubation of the Biotech Technology Institute.

This institute will play a pivotal role in providing employment and self-employment opportunities to approximately 400 students from pharmacy and biotechnology institutes. Moreover, it will serve as a hub for collaboration among scientists to brainstorm and develop new technologies, thereby enhancing the state’s capabilities in these critical sectors.

Related Posts

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

The Central Drugs Standard Control Organisation (CDSCO) found one spurious and 220 not of standard quality (NSQ) drug samples from a batch tested randomly as part of the August drug…

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

The action follows the department’s investigation into a large-scale unlicenced drug repacking and relabelling racket uncovered at a farmhouse in Bengaluru South district’s Bidadi on August 18. The Karnataka Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman